Caplight Logo









Genepoint Biological Technology

Genepoint Biological Technology

Private
Shanghai, ShanghaiHealthcare & Life Scienceshttps://www.genepoint.cn

Last Round

Series D

Jan 18, 2023

Total Funding Raised

$67.15M

Company Overview

Genepoint is a biotechnology company that specializes in automated storage systems to support research and development by enhancing cryogenic robotic systems for biological samples.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Warehouse Automation, Industrial Robotics

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

biobank automationautomated sample storagecryogenic roboticscryopreservationautomated biobankrobotic repositorylab automationcryo-automationcryogenic storagesample managementbiotech equipmentautomated freezerlife sciences equipmentsample traceabilitylab transport robotLIMS integrationcryotubes

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genepoint Biological Technology Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Genepoint Biological Technology Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series DJan 18, 2023
Series C ExtensionFeb 7, 2022
Series C ExtensionJul 12, 2021
Series CJun 9, 2021
Series BAug 24, 2018
Series A
Jul 24, 2017

Genepoint Biological Technology Investors

Notable investors and investment history

InvestorRounds
Bangming CapitalSeries A
Zhongke GuoshengSeries D
Day One CapitalSeries D, Series C, Series C Extension
Northern Light Venture CapitalSeries C
LYFE CapitalSeries D, Series C Extension
Shanghai Guofang Private Equity Fund ManagementSeries D
Huajin CapitalSeries D

Genepoint Biological Technology Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Genepoint Biological Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Genepoint Biological Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai, Shanghai
Employee Range4
Year Founded2015
Last FundingJan 18, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.